Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls

Annals of the Rheumatic Diseases

Volumn 55, Issue 1, 1996, Pages 40-46

  Goodstone, Nicola J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN;

ADULT; AGED; ARTICLE; CARTILAGE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030058361     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.1.40     Document Type: Article

References (6)

1. Panayi G S. The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol 1993; 32: 4-14.
2. Champion B R, Poole A R. Immunity to homologous cartilage proteoglycans in rabbits with chronic inflammatory arthritis. Matrix 1981; 1: 453-73.
3. Glant T T, Olah I. Experimental arthritis produced by proteoglycan antigen in rabbits. Scand J Rheumatol 1980; 9: 271-9.
4. Glant T T. Immunology in the pathogenesis of cartilage degradation in experimental arthritis. Semin Arthritis Rheum 1981; 11: 107-8.
5. Glant T T. Induction of cartilage degradation in experimental arthritis produced by allogeneic and xenogeneic proteoglycan antigens. Connect Tissue Res 1982; 9: 137-44.
6. Mikecz K, Giant T T, Poole A R. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987; 11: 107-8.